ClinicalTrials.gg

Program

MCV4

Its studies are mostly in Meningitis, Meningococcal · Diphtheria, led by CanSino Biologics.

Furthest: phase 4, since Jun 27, 20236 company-led studies, 3 open or runningNext primary completion: Feb 2029 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
CanSino Biologics63 open or runningphase 4since Jun 27, 2023Jun 27, 2023Feb 2029phase 1 · NCT07203755

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jun 27, 2023First study: phase 4 study in Meningitis, MeningococcalFirst studyNCT05935176 · 660 enrolled · China
  2. Aug 15, 2023Phase 3 study in Meningitis, MeningococcalNCT06011200 · 1,000 enrolled · China
  3. Jan 18, 2024Phase 3 study in Meningitis, MeningococcalNCT06226714 · 840 enrolled · China
  4. Apr 24, 2024Phase 4 study in Meningitis, MeningococcalNCT06389513 · 3,011 enrolled · China
  5. Nov 19, 2024Phase 3 study in Meningitis, MeningococcalNCT06700148 · 840 enrolled · China
  6. Sep 25, 2025Phase 1 study in DiphtheriaNCT07203755 · 260 planned · China

Ahead

  1. Feb 2029Primary completion: phase 1 study in DiphtheriaNCT07203755

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07203755Diphtheria · China1RecruitingFeb 2029260
NCT06700148Meningitis, Meningococcal · China3CompletedFeb 19, 2025840
NCT06389513Meningitis, Meningococcal · China4CompletedApr 10, 20263,011
NCT06226714Meningitis, Meningococcal · China3Active, not recruitingSep 26, 2024840
NCT06011200Meningitis, Meningococcal · China3CompletedDec 11, 20231,000
NCT05935176Meningitis, Meningococcal · China4Active, not recruitingMay 15, 2026660

How it is read

Names in the registry

  • “MCV4”, 9 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 14, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.